moclobemid sandoz 150 mg filmtabletta
sandoz hungária kft. - moklobemid -
moclobemid sandoz 300 mg filmtabletta
sandoz hungária kft. - moklobemid -
haloperidol-richter 1,5 mg tabletta
richter gedeon nyrt. - a haloperidol -
haloperidol-richter 5 mg/ml oldatos injekció
richter gedeon nyrt. - a haloperidol -
haloperidol decanoat-richter 50 mg/ml oldatos injekció
richter gedeon nyrt. - a haloperidol -
omicral 100 mg kemény kapszula
bausch health ireland ltd. - itrakonazol -
haloperidol-richter 2 mg/ml belsőleges oldatos cseppek
richter gedeon nyrt. - a haloperidol -
itraconep 100 mg kemény kapszula
extractum-pharma zrt. - itrakonazol -
methylthioninium chloride proveblue
provepharm sas - metil-tionin-klorid - methaemoglobinaemia - minden más terápiás készítmény - gyógyászati és vegyi eredetű methemoglobinémák akut tüneti kezelése. methylthioninium-klorid proveblue jelzi a felnőttek, gyermekek, serdülők (0 17 éves).
zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.